Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$550K Hold
2,690
0.02% 112
2017
Q1
$491K Buy
2,690
+58
+2% +$10.1K 0.02% 118
2016
Q4
$422K Buy
2,632
+117
+5% +$17.2K 0.02% 123
2016
Q3
$355K Buy
2,515
+1
+0% +$139 0.01% 127
2016
Q2
$343K Buy
2,514
+502
+25% +$66.6K 0.02% 131
2016
Q1
$272K Buy
2,012
+453
+29% +$61.2K 0.01% 149
2015
Q4
$234K Buy
1,559
+14
+0.9% +$2.07K 0.01% 159
2015
Q3
$206K Buy
+1,545
New +$216K 0.01% 272

Other funds holding CHE

Ronald Blue & Co's CHE Position: Q2 2017 in Review

Ronald Blue & Co held its Chemed (CHE) position steady in Q2 2017 at 2,690 shares worth $550K. The position accounts for 0.02% of the portfolio, ranked #112.

Ronald Blue & Co first reported a position in CHE in Q3 2015 and has held it in 8 quarters since. 272 funds tracked by Wall St. Rank hold CHE as of Q2 2017.

  • Ronald Blue & Co held 2,690 shares of Chemed worth $550K as of Q2 2017.
  • Ronald Blue & Co left its Chemed share count unchanged in Q2 2017.
  • Chemed made up 0.02% of Ronald Blue & Co's portfolio in Q2 2017, its #112 holding.
  • Ronald Blue & Co first reported a position in Chemed in Q3 2015 and has held it in 8 quarters since.
  • 272 funds tracked by Wall St. Rank held Chemed as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.